BX2 Needle Guide, Part Number 644-094, tool for performing needle-guided (or catheter) procedures...

FDA Device Recall #Z-1892-2025 — Class II — May 1, 2025

Recall Summary

Recall Number Z-1892-2025
Classification Class II — Moderate risk
Date Initiated May 1, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Civco Medical Instruments Co. Inc.
Location Kalona, IA
Product Type Devices
Quantity 506 boxes

Product Description

BX2 Needle Guide, Part Number 644-094, tool for performing needle-guided (or catheter) procedures with the use of diagnostic ultrasound transducers

Reason for Recall

During the attachment of the needle guide to the covered probe, the tight tolerance and fit of the needle guide can cause a pinhole breach in the transducer cover when latching the guide in place.

Distribution Pattern

OUS Distribution to countries of: Japan, Taiwan, France, Georgia, Germany and Denmark

Lot / Code Information

UDI-DI: 00841436120050; Lot Numbers: A174424, A176855, A177208, A182744, A184023, A185336, A185337, A186904, A189734, A190489, A193623, A194755, A198716, A198795, A199940, A200430, A202208, A203169, A203201, A203520, A205457, A207901, A208740, A211619, A212291, A213027, A215531, A216885, A217412, A220102, A221365, A221925, A225145, A226800, A228446, A228778, A229092, A229898, A230045, A230054, A230549, A230581, A231101, A231810, A232903, A233075, A233535, A236538, A238767, A239339, A239355, A240873, A240931, A241445, A242018, A242161, A243263, A243264, A245342, A245527, A246173, A248520, A248572, A250325, A252513, A252842, A254080, A254081, A254900, A254955, A255332, A257534, A258150, A258926, A260607

Other Recalls from Civco Medical Instruments Co. Inc.

Recall # Classification Product Date
Z-0397-2022 Class II VirtuTRAX Instrument Navigator, Sensor with 10 ... Oct 8, 2021
Z-0395-2022 Class II VirtuTRAX Instrument Navigator, Sensor with 14 ... Oct 8, 2021
Z-0398-2022 Class II VirtuTRAX Instrument Navigator, 10 17 GA VirtuTRAX Oct 8, 2021
Z-0396-2022 Class II VirtuTRAX Instrument Navigator, 14 Ga VirtuTRAX Oct 8, 2021
Z-2947-2018 Class II CIVCO Needle Guide, REF 676-150, QTY 24, STERIL... Jul 30, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.